We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • July 1st, 2021 • Caribou Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 1st, 2021 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (this “Agreement”) is made as of March 2, 2021 by and among Caribou Biosciences, Inc. a Delaware corporation (the “Company”), the Investors listed on Schedule A and the Key Holders listed on Schedule B.
SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • May 7th, 2021 • Caribou Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 7th, 2021 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (this “Agreement”) is made as of March 2, 2021 by and among Caribou Biosciences, Inc. a Delaware corporation (the “Company”), the Investors listed on Schedule A and the Key Holders listed on Schedule B.